Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Endocrinology Service, Medicine Service, Rocky Mountain Regional Veterans Affairs Medical Center, Eastern Colorado Health Care System, Aurora, CO 80045, USA.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):592-602. doi: 10.1210/clinem/dgad536.
While endocrinologists continue to initiate gender-affirming hormone therapy (GAHT) in healthy transgender and gender diverse (TGD) patients, they may also encounter more TGD patients in their clinics with complex medical histories that influence the patient-provider shared decision-making process for initiating or continuing GAHT. The purpose of this Approach to the Patient article is to describe management considerations in 2 adults with thromboembolic disease and 2 adults with low bone mineral density in the setting of feminizing and masculinizing GAHT.
虽然内分泌学家继续为健康的跨性别和性别多样化（TGD）患者启动性别肯定激素治疗（GAHT），但他们在诊所中也可能会遇到更多具有复杂病史的 TGD 患者，这些病史会影响启动或继续 GAHT 的医患共同决策过程。本文的目的是描述在接受女性化和男性化 GAHT 治疗的 2 例血栓栓塞性疾病患者和 2 例低骨密度患者的管理注意事项。
